Article
CHI3L1 predicted in malignant entities is associated with glioblastoma immune microenvironment
14 Oct 2022
Abstract excerpt
Effective immunotherapies for patients with glioblastoma (GBM) are urgently needed. Chitinase-3 like-protein-1 (CHI3L1) play important roles in the development of gliomas. However, its role in glioma-related immune responses remains unclear. We aimed to comprehensively investigate its biological features and clinical value in glioma, especially in GBM. Transcriptome, proteome and single-cell RNA-sequencing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
